Publications
Engineering prokaryotic channels for control of mammalian tissue excitability." Nature communications 7 (2016).
"Engineering of Functional Cardiac Tissue Patch with Realistic Myofiber Orientations." CIRCULATION 122, no. 21 (2010).
"Engineering human pluripotent stem cells into a functional skeletal muscle tissue." Nature communications 9, no. 1 (2018).
"Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies." Nature communications 2 (2011): 300.
"Engineered Somatic Cells for Cardiac Repair." CIRCULATION 122, no. 21 (2010).
"Engineered skeletal muscles for disease modeling and drug discovery." Biomaterials 221 (2019).
"Engineered skeletal muscle tissue networks with controllable architecture." Biomaterials 30, no. 7 (2009): 1401-1412.
"An Engineered Optogenetic Switch for Spatiotemporal Control of Gene Expression, Cell Differentiation, and Tissue Morphogenesis." ACS synthetic biology 6, no. 11 (2017): 2003-2013.
"Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation." Biomaterials 159 (2018): 48-58.
"Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy." Nat Commun 13, no. 1 (2022).
"Electrotonic loading of anisotropic cardiac monolayers by unexcitable cells depends on connexin type and expression level." American journal of physiology. Cell physiology 297, no. 2 (2009): C339-C351.
"Electrical stimulation increases hypertrophy and metabolic flux in tissue-engineered human skeletal muscle." Biomaterials 198 (2019): 259-269.
"Electrical pacing counteracts intrinsic shortening of action potential duration of neonatal rat ventricular cells in culture." Journal of molecular and cellular cardiology 41, no. 4 (2006): 633-641.
"Effect of Electromechanical Stimulation on the Maturation of Myotubes on Aligned Electrospun Fibers." Cellular and molecular bioengineering 1, no. 2-3 (2008): 133-145.
"Dynamic culture yields engineered myocardium with near-adult functional output." Biomaterials 111 (2016): 66-79.
"Distilling complexity to advance cardiac tissue engineering." Science translational medicine 8, no. 342 (2016).
"Differential Response of Engineered Human Cardiac Tissues to Delta and Omicron COVID-19 Virus." J Am Heart Assoc 12, no. 12 (2023).
"Differential microRNA profiles of intramuscular and secreted extracellular vesicles in human tissue-engineered muscle." Front Physiol 13 (2022).
"Developmental stage-dependent effects of cardiac fibroblasts on function of stem cell-derived engineered cardiac tissues." Scientific reports 7 (2017).
"Design, Evaluation, and Application of Engineered Skeletal Muscle." Methods (2015).
"Design, evaluation, and application of engineered skeletal muscle." Methods (San Diego, Calif.) 99 (2016): 81-90.
"Design considerations for an integrated microphysiological muscle tissue for drug and tissue toxicity testing." Stem Cell Res Ther 4 Suppl 1, no. Suppl 1 (2013).
"Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties." Tissue engineering 9, no. 6 (2003): 1243-1253.
"CRISPR Library Screening in Cultured Cardiomyocytes." Methods in molecular biology (Clifton, N.J.) 2485 (2022): 1-13.
"Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure." Circ Res 124, no. 1 (2019): 161-169.
"